NCT06663787 2025-11-28
HER2 CR
Nagoya City University
Active not recruiting
Clinical Trials
12 trialsNCT07180264 2025-11-18
Trastuzumab Deruxtecan in Advanced Breast Cancer
RenJi Hospital
Recruiting
NCT06386263 2025-10-15
HER-TEMPO
AstraZeneca
Completed
NCT06504719 2025-09-15
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
Hellenic Cooperative Oncology Group
Completed
NCT06727227 2025-07-01
EXPLORE
AstraZeneca
Recruiting
NCT07035353 2025-06-25
A Real-world Clinical Study of T-DXd for the Treatment of Chinese Patients With HER2 Overexpressing and HER2 Underexpressing Advanced Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting
NCT07030569 2025-06-22
RADIOSPHER2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT06231693 2025-05-08
Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
AstraZeneca
Terminated
NCT06551220 2024-12-04
HEROIC
Sun Yat-sen University
Recruiting
NCT05458401 2024-03-15
EUROPA T-DXd
Daiichi Sankyo
Completed
NCT06135194 2023-11-18
Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior Pyrotinib
Beijing 302 Hospital
Unknown
NCT05594082 2023-04-04
Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer
Fudan University
Unknown